SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions. (Q37936542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

review article

1 reference

title

SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sandrine Dallet-Choisy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Marie-Louise Zani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Annabelle Tanga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hélène Serrano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Kévin Baranger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Thierry Moreau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

Biochemical Society Transactions

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1441-1446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Neutrophil serine proteases fine-tune the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Antimicrobial proteins and polypeptides in pulmonary innate defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

SLPI and elafin: one glove, many fingers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Antimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elafin gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Identification and sequence analysis of two new members of the SKALP/elafin and SPAI-2 gene family. Biochemical properties of the transglutaminase substrate motif and suggestions for a new nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Transglutaminase 2 and nucleoside diphosphate kinase activity are correlated in epithelial membranes and are abnormal in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Inhaled recombinant alpha 1-antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

Induction of SLPI (ALP/HUSI-I) in Epidermal Keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST0391441

21 January 2018

Identifiers

DOI

10.1042/BST0391441

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21936830%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference